Intravenous thrombolysis versus early antiplatelet therapy in acute ischaemic stroke with small artery occlusion.

Standardising the diagnosis and imaging of intracranial atherosclerotic stenosis in Asia: a call for regional consensus.

Phase I dose-escalation study of tenecteplase, a third-generation fibrinolytic agent, combined with neuronavigation-assisted stereotactic minimally invasive puncture, in patients with acute spontaneous deep cerebral haemorrhage.

Macular choriocapillaris perfusion area: a potential biomarker of mild cognitive impairment in patients with cerebral small vessel disease.

Characteristics of brain structural damage related to cerebral small vessel disease in general population with intracranial artery stenosis.

Dual versus mono antiplatelet therapy within 72 hours after onset for mild ischaemic stroke or transient ischaemic attack: meta-analysis of randomised controlled trials.

Intravenous thrombolysis versus early antiplatelet therapy in acute ischaemic stroke with small artery occlusion.

Standardising the diagnosis and imaging of intracranial atherosclerotic stenosis in Asia: a call for regional consensus.

Phase I dose-escalation study of tenecteplase, a third-generation fibrinolytic agent, combined with neuronavigation-assisted stereotactic minimally invasive puncture, in patients with acute spontaneous deep cerebral haemorrhage.

Macular choriocapillaris perfusion area: a potential biomarker of mild cognitive impairment in patients with cerebral small vessel disease.

Characteristics of brain structural damage related to cerebral small vessel disease in general population with intracranial artery stenosis.

Dual versus mono antiplatelet therapy within 72 hours after onset for mild ischaemic stroke or transient ischaemic attack: meta-analysis of randomised controlled trials.